Peer-influenced content. Sources you trust. No registration required. This is HCN.
Eyewire+
The Icahn School of Medicine at Mount Sinai has launched a pioneering center dedicated to the advancement of AI in ophthalmology. This initiative aims to transform patient care and research, focusing on early detection and intervention of various eye diseases and related systemic conditions.
Ophthalmology August 23rd 2023
Northwestern Medicine
Northwestern Medicine’s recent study uncovers a novel interaction between lysosomes and mitochondria, disrupted by mutations in the parkin gene, contributing to Parkinson’s disease. This discovery offers a new therapeutic pathway and emphasizes the significance of organelle communication in neurodegenerative disorders.
Neurology August 22nd 2023
Roswell Park
The recent study by Roswell Park Comprehensive Cancer Center demonstrates that exercise may significantly impact the immune system in multiple myeloma patients. Explore the potential of this nonpharmaceutical approach to enhance immune function and provide a new avenue for controlling this blood cancer.
Hematology/Oncology August 14th 2023
Dana-Farber Cancer Institute
A recent study on glioma brain tumors reveals the significant role of epigenetic changes in tumor formation. This discovery offers promising avenues for targeted therapies, potentially transforming the approach to treating this devastating disease.
Medical Oncology August 14th 2023
The field of gastric and esophageal cancer treatment is witnessing remarkable advancements through targeted therapies and immunotherapies. Explore the latest clinical trials and discoveries that are redefining the standard of care for these traditionally difficult-to-treat cancers.
Gastroenterology August 1st 2023
Researchers at Roswell Park Comprehensive Cancer Center have unveiled a novel approach using bispecific T-cell engagers (BiTEs) to enhance immune responses against ovarian cancer. This promising pathway may lead to improved therapeutic options for patients unresponsive to conventional immunotherapies.
Medical Oncology August 1st 2023